Medicare Part D does not cover Wegovy when it is prescribed for weight loss alone, because federal law excludes weight loss agents from the benefit. Coverage became possible only after Wegovy earned a separate approval for reducing cardiovascular risk — and even then, coverage is permitted rather than required, so it depends on your individual plan’s formulary.
This is one part of getting a GLP-1 covered. For the full picture, see GLP-1 Insurance Coverage: The Complete Guide.
Why the indication matters more than the drug
Part D’s statutory exclusion covers agents used for weight loss. For most of Wegovy’s life, that was its only approved use, so the answer was a flat no regardless of plan.
That changed when Wegovy received an additional FDA approval for reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight. That indication is not weight loss. It is cardiovascular risk reduction, which sits outside the exclusion.
The distinction sounds like a technicality. It is the entire difference between coverage and no coverage.
What this means in practice
Three conditions generally have to line up.
You need established cardiovascular disease documented in your record — not risk factors, but diagnosed disease. You need obesity or overweight. And your specific Part D plan has to have chosen to add Wegovy to its formulary for that indication, because permission to cover is not the same as an obligation to cover.
Expect a prior authorization. The plan will want to see the cardiovascular diagnosis coded, because that diagnosis is doing all the work.
All three must be true for Part D coverage1 Established cardiovascular disease, coded +2 Obesity or overweight documented +3 Your plan added it to its formulary for that useWeight loss alone does not qualify, regardless of BMI.How to check your own plan
Log into your Part D plan portal and search the formulary for Wegovy. Note the tier, and note whether PA, ST, or QL appears beside it. Then call member services and ask specifically: “Is Wegovy on my formulary for the cardiovascular risk reduction indication, and what does the prior authorization require?”
Ask for a call reference number. If the answer differs from what you find later, that number matters.
If you don’t have cardiovascular disease
Then Part D coverage for Wegovy is generally not available to you, and no amount of documentation changes that, because the barrier is statutory rather than clinical.
What remains is self-pay, which for most people means comparing the manufacturer’s direct-purchase pricing against pharmacy cash prices, or a conversation with your prescriber about whether a different agent with an indication your plan covers would be clinically appropriate.
Be aware that manufacturer savings cards are typically closed to anyone on a federal program, so the assistance route most commercially insured patients use is usually unavailable.
This area changes
Coverage policy for GLP-1 medications under Medicare has been the subject of repeated proposals and reversals. Anything written about it has a shelf life. Before making a decision, confirm the current position through Medicare.gov or your plan directly.
The cardiovascular indication is what opened this route, and the SELECT trial behind it explains who it applies to. For the parallel case under a different condition, see Medicare and the Zepbound sleep apnea indication.
Frequently asked questions
I have high blood pressure and high cholesterol. Is that cardiovascular disease?
Those are risk factors, not established disease. The indication generally requires diagnosed cardiovascular disease such as prior heart attack, stroke, or peripheral arterial disease. Your prescriber can tell you how your record is coded.
Can I appeal a Wegovy denial under Medicare?
Yes, Part D has a formal appeals process with defined levels. But if the denial rests on the statutory weight loss exclusion, an appeal on clinical grounds is unlikely to succeed.
Does Medicare Advantage cover it?
Advantage plans deliver the Part D benefit and are bound by the same exclusion. Some offer supplemental benefits, so it is worth asking directly.
What if I switch to a plan that covers it?
Formularies differ, so during open enrollment it is worth comparing plans on this specific drug using the Medicare Plan Finder.
Is Ozempic easier to get covered?
For someone with type 2 diabetes, yes, because that is its approved indication. It is not a workaround for someone without diabetes.
Does the savings card work?
Generally not for people enrolled in Medicare. Check the program terms before relying on it.
Sources
- Social Security Act §1860D-2(e)(2), excluded drug categories — ssa.gov
- FDA Prescribing Information, Wegovy (semaglutide) injection — accessdata.fda.gov
- Medicare Plan Finder — medicare.gov